Wach, S.
237  Ergebnisse:
Personensuche X
?
 
?
 
?
8

Divergent immunobiological correlates of FDA-/EMA-approved ..:

Weyerer, V ; Geppert, CI ; Bertz, S...
Urologic Oncology: Seminars and Original Investigations.  38 (2020)  12 - p. 908 , 2020
 
?
9

Heterogeneity-analysis of molecular subtypes of muscle-inva..:

Weyerer, V ; Lange, F ; Wullweber, A...
Urologic Oncology: Seminars and Original Investigations.  38 (2020)  12 - p. 907 , 2020
 
?
 
?
11

Cytotoxic T cell related gene expression signature predicts..:

Eckstein, M. ; Wirtz, R. ; Strissel, P....
European Urology Supplements.  18 (2019)  1 - p. e587-e588 , 2019
 
?
12

Androgen receptor mRNA expression in urothelial carcinoma o..:

Sikic, D. ; Wirtz, R.M. ; Wach, S....
European Urology Supplements.  18 (2019)  1 - p. e317 , 2019
 
?
 
?
14

Performance of FDA/EMA approved PD-L1 assays in urothelial ..:

Eckstein, M. ; Erben, P. ; Kriegmair, M....
European Urology Supplements.  18 (2019)  1 - p. e308-e309 , 2019
 
?
15

Tumor immune microenvironment drives prognostic relevance c..:

Strissel, P. ; Pfannstiel, C. ; Chiappinelli, K....
European Urology Supplements.  18 (2019)  1 - p. e1455-e1456 , 2019
 
1-15